Exscientia Plc - American Depositary Shares (NQ:EXAI)

Founded in 2012 and based in Oxford, England, Exscientia Plc is using Artificial Intelligence to develop new medicines and is attracting high-quality partners. It has a rapidly growing pipeline of more...

Top Picks 2024: Exscientia Plc ↗

December 31, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.

Topics Artificial Intelligence

AI-Focused Drug Discovery Stocks Index Up 26% In December ↗

December 29, 2023

Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme

December 21, 2023

A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.

Earnings Outlook For Exscientia ↗

November 08, 2023

Via Benzinga

Analyst Expectations for Exscientia's Future ↗

October 11, 2023

Via Benzinga

AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week ↗

December 17, 2023

If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...

Topics Artificial Intelligence

The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week ↗

December 11, 2023

Exscientia has the potential to be a star collaborator and a profitable drug developer, too.

Topics Artificial Intelligence

Looking for the Next Big Thing? Add This AI Biotech to Your Watch List Right Now ↗

December 07, 2023

Via The Motley Fool

Topics Artificial Intelligence

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November ↗

December 06, 2023

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.

Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza

Topics Artificial Intelligence

December 05, 2023

Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference

November 21, 2023

AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.

Unlocking AI investment opportunities in healthcare

November 16, 2023

Via MarketBeat

Topics Artificial Intelligence ETFs

3 Cutting-Edge Biotech Stocks for the Bold Investor ↗

November 14, 2023

With broader market concerns rising, investors may want to consider the relatively insulated allure of biotech stocks to buy.

Via InvestorPlace

Exscientia Business Update for Third Quarter 2023

November 09, 2023

Exscientia to Report Third Quarter 2023 Financial Results on November 9, 2023

November 02, 2023

Three of the most important AI trends will involve its role in enhancing autos and healthcare, as well as the development of localized AI.

3 Trends in Artificial Intelligence to Watch in 2024 ↗

October 31, 2023

Via InvestorPlace

Topics Artificial Intelligence

Parker Moss to Join Exscientia as EVP, Corporate Development

October 17, 2023

Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ESMO 2023

October 16, 2023

Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 11, 2023

Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in...

Via Benzinga

AZZ, VOXX International And Other Big Stocks Moving Higher On Wednesday ↗

October 11, 2023

U.S. stocks traded higher Wednesday, with the Dow Jones gaining around 100 points. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Exscientia Details Pipeline Prioritisation Strategy

October 03, 2023

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet ↗

September 22, 2023

Investors are constantly on the hunt for undervalued, under-followed, and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance...

Via Benzinga

Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 21, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.

Via Benzinga

FedEx, Splunk, FactSet Research And Other Big Stocks Moving Higher On Thursday ↗

September 21, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling over 1% on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 20, 2023

Via Benzinga

Exscientia Shares Surge On AI Collaboration: The Details ↗

September 20, 2023

Exscientia Plc (NASDAQ: EXAI) shares are trading higher Wednesday after the company announced an AI drug discovery collaboration with Merck KGaA,

Via Benzinga

Topics Artificial Intelligence

Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket ↗

September 20, 2023

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday.

Via Benzinga

Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany

September 20, 2023